1982
DOI: 10.1016/0005-2760(82)90127-8
|View full text |Cite
|
Sign up to set email alerts
|

Arachidonic acid metabolism by cultured mesothelial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

1987
1987
2004
2004

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(4 citation statements)
references
References 13 publications
0
4
0
Order By: Relevance
“…The basic concepts of intraperito neal chemotherapy developed from peritoneal dialysis studies, many of which yielded new insight into the func tion of human peritoneal mésothélial cells (HPMC). It has been demonstrated that a monolayer of mésothélial cells not only lines the peritoneal cavity and forms an active permeability barrier regulating the passage of fluid and solutes across the peritoneal membrane [4] but also due to its significant biosynthetic capacity is a major source of peritoneal phospholipids [5], prostaglandins [6] and cyto kines [7,8], During peritoneal dialysis HPMC are continually ex posed to a nonphysiological environment of the dialysis solution. In this respect previous studies of peritoneal biopsy material from patients on chronic peritoneal dialy sis have revealed many alterations in mesothelial cell morphology including loss of the surface microvilli, dis-ruption of the intercellular junctions, and detachment from the subjacent tissue [9], It has also been shown that unused dialysis fluids significantly reduce HPMC viabili ty in vitro [10].…”
Section: Introductionmentioning
confidence: 99%
“…The basic concepts of intraperito neal chemotherapy developed from peritoneal dialysis studies, many of which yielded new insight into the func tion of human peritoneal mésothélial cells (HPMC). It has been demonstrated that a monolayer of mésothélial cells not only lines the peritoneal cavity and forms an active permeability barrier regulating the passage of fluid and solutes across the peritoneal membrane [4] but also due to its significant biosynthetic capacity is a major source of peritoneal phospholipids [5], prostaglandins [6] and cyto kines [7,8], During peritoneal dialysis HPMC are continually ex posed to a nonphysiological environment of the dialysis solution. In this respect previous studies of peritoneal biopsy material from patients on chronic peritoneal dialy sis have revealed many alterations in mesothelial cell morphology including loss of the surface microvilli, dis-ruption of the intercellular junctions, and detachment from the subjacent tissue [9], It has also been shown that unused dialysis fluids significantly reduce HPMC viabili ty in vitro [10].…”
Section: Introductionmentioning
confidence: 99%
“…Mesothelial cells play important roles in both peritoneal transport functions and remodeling, the latter through its controlled synthesis of cytokines, chemokines, growth factors, prostaglandins, and matrix proteins (1)(2)(3)(4). Injury to the mesothelium represents an important initiating step, leading to the progressive histologic changes of the peritoneum in peritoneal dialysis (PD).…”
mentioning
confidence: 99%
“…2 A). At 6 h, the total number of neutrophils recovered from the pleural spaces exposed to TNF was more than threefold greater than that from the opposite side (Table I). There was no increase in the entry of radiolabeled protein.…”
Section: Resultsmentioning
confidence: 93%
“…Although previously considered a passive lining cell, pleural mesothelial cells exhibit a variety of functions that suggest that they play a role in the pathogenesis of inflammation. For example, mesothelial cells have been shown to phagocytose particles including asbestos fibers (5), produce prostaglandins in response to nonspecific irritants (6), and express immune-associated antigens in response to interferon-^y (7). In a recent report by Antony et al (8), rabbit pleural mesothelial cells were shown to produce a neutrophil chemotaxin, a 6-9-kD peptide.…”
mentioning
confidence: 99%